Literature DB >> 12644228

HIV Tat, its TARgets and the control of viral gene expression.

Claudio Brigati1, Mauro Giacca, Douglas M Noonan, Adriana Albini.   

Abstract

The human immunodeficiency virus (HIV-1) (transactivator of transcription (Tat)) protein is a pleiotropic factor that induces a broad range of biological effects in numerous cell types. At the HIV promoter, Tat is a powerful transactivator of gene expression, which acts by both inducing chromatin remodeling and by recruiting elongation-competent transcriptional complexes onto the viral LTR. Besides these transcriptional activities, Tat is released outside the cells and interacts with different cell membrane-associated receptors. Finally, extracellular Tat can be internalized by cells through an active endocytosis process. Here we discuss some of the molecular mechanisms involved in intracellular and extracellular Tat function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644228     DOI: 10.1016/S0378-1097(03)00067-3

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  36 in total

1.  Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.

Authors:  Yujie Liu; Michael R Nonnemacher; Devin L Stauff; Luna Li; Anupam Banerjee; Bryan Irish; Evelyn Kilareski; Nirmala Rajagopalan; Joyce B Suchitra; Zafar K Khan; Udaykumar Ranga; Brian Wigdahl
Journal:  Biomed Pharmacother       Date:  2010-09-25       Impact factor: 6.529

2.  Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.

Authors:  Yan Desfosses; Mayra Solis; Qiang Sun; Nathalie Grandvaux; Carine Van Lint; Arsene Burny; Anne Gatignol; Mark A Wainberg; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 3.  Immune modulation by estrogens: role in CNS HIV-1 infection.

Authors:  Melinda E Wilson; Filomena O Dimayuga; Janelle L Reed; Thomas E Curry; Carol F Anderson; Avindra Nath; Annadora J Bruce-Keller
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  Ubiquitination of tombusvirus p33 replication protein plays a role in virus replication and binding to the host Vps23p ESCRT protein.

Authors:  Daniel Barajas; Peter D Nagy
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

5.  Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters.

Authors:  Mainul Hoque; Michael B Mathews; Tsafi Pe'ery
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

6.  Molecular basis of the internalization of bovine immunodeficiency virus Tat protein.

Authors:  Gang Deng; Yang Su; Junjie Mu; Rina Sha; Yunqi Geng; Wentao Qiao; Qimin Chen
Journal:  Virus Genes       Date:  2007-10-19       Impact factor: 2.332

7.  HIV promoter integration site primarily modulates transcriptional burst size rather than frequency.

Authors:  Ron Skupsky; John C Burnett; Jonathan E Foley; David V Schaffer; Adam P Arkin
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

8.  Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia.

Authors:  Paula M Heron; Jadwiga Turchan-Cholewo; Annadora J Bruce-Keller; Melinda E Wilson
Journal:  AIDS Res Hum Retroviruses       Date:  2009-11       Impact factor: 2.205

9.  HIV Tat potentiates cell toxicity in a T cell model for sulphamethoxazole-induced adverse drug reactions.

Authors:  Kemi Adeyanju; Adriana Krizova; Philippe A Gilbert; Gregory A Dekaban; Michael Rieder
Journal:  Virus Genes       Date:  2009-03-10       Impact factor: 2.332

10.  Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study.

Authors:  Sylvia Fitting; Rosemarie M Booze; Ulla Hasselrot; Charles F Mactutus
Journal:  Hippocampus       Date:  2010-04       Impact factor: 3.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.